CDT Equity (CDT) Long-Term Investments (2022 - 2026)
CDT Equity's (CDT) quarterly Long-Term Investments came in at $122.9 million in Q1 2026, up 427.61% on a QoQ basis from $23.3 million in Q2 2023.
CDT Equity (CDT) Long-Term Investments (2022 - 2026) Analysis & Trends
CDT Equity (CDT) has 3 years of Long-Term Investments data on file, last reported at $122.9 million in Q1 2026.
- Quarterly Long-Term Investments changed N/A year-over-year to $122.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $122.9 million (changed N/A YoY) and the FY2022 annual result came in at $136.9 million, changed N/A from the prior year.
- Long-Term Investments climbed to $122.9 million in Q1 2026, from $23.3 million in the prior quarter.
- In the past five years, Long-Term Investments ranged from a high of $136.9 million in Q4 2022 to a low of $23.3 million in Q2 2023.
- A 3-year average of $101.8 million and a median of $134.9 million in 2022 frame the typical range for Long-Term Investments.
- The widest YoY moves for Long-Term Investments: up 82.46% in 2023, down 82.75% in 2023.
- Tracing CDT's Long-Term Investments over 3 years: stood at $136.9 million in 2022, then slumped by 82.98% to $23.3 million in 2023, then surged by 427.61% to $122.9 million in 2026.
- The last three Long-Term Investments figures came in at $122.9 million (Q1 2026), $23.3 million (Q2 2023), and $23.7 million (Q1 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 5.79 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 9.83 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 1.77 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 22.17 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 372.10 Mn |
| 10 | CDT Equity | 1.55 Mn | 1.55 Mn | - | 122.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 122.85 Mn |
| Mar 31, 2026 | 122.93 Mn |
| Jun 30, 2023 | 23.30 Mn |
| Mar 31, 2023 | 23.66 Mn |
| Dec 31, 2022 | 136.90 Mn |
| Sep 30, 2022 | 135.71 Mn |
| Jun 30, 2022 | 135.10 Mn |
| Mar 31, 2022 | 134.91 Mn |